Avirmax

Avirmax

Biotechnology, Whitesell St, Hayward, , 94541, California, 25503, United States, 11-50 Employees

avirmax.com

  • twitter
  • LinkedIn

Who is AVIRMAX

Avirmax, Inc. based in San Francisco Bay Area, is dedicated to innovate, develop and manufacture adeno-associated virus (AAV) vector mediated biotherapeutics using its proprietary protein...

Read More

map
  • 25503 Whitesell St, Hayward, California, 94541, United States Headquarters: 25503 Whitesell St, Hayward, California, 94541, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AVIRMAX

Avirmax Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Avirmax

Answer: Avirmax's headquarters are located at Whitesell St, Hayward, , 94541, California, 25503, United States

Answer: Avirmax's official website is https://avirmax.com

Answer: Avirmax's revenue is $1 Million to $5 Million

Answer: Avirmax's SIC: 8731

Answer: Avirmax's NAICS: 541714

Answer: Avirmax has 11-50 employees

Answer: Avirmax is in Biotechnology

Answer: Avirmax contact info: Phone number: Website: https://avirmax.com

Answer: Avirmax, Inc. based in San Francisco Bay Area, is dedicated to innovate, develop and manufacture adeno-associated virus (AAV) vector mediated biotherapeutics using its proprietary protein therapeutics and BAC-to-AAV technologies. Avirmax Adeno-associated Vector Innovation Platform (AAVIP), enables us to become a powerhouse of rAAV therapeutics for its very infectious AAV vectors with high titers at production and enhanced expression of gene of interest (GOI) in target cells. Our ultimate goal is to deliver patients with the effective, safe, long-acting AAV-mediated biotherapeutics at the most affordable and accessible manner. Avirmax, Inc is dedicated to innovate and develop novel technologies to address current challenges in viral vector production based on its state of the art AAV bioprocess technologies in combination with Viroveks BAC-to-AAV insect system. Avirmax has established robust rAAV vector production technologies for small and large-scale applications using Sf9-Baculovirus system.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access